Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis

已完结 10 由 honey 发布于 2026/10/22 10:21:56

DOI:10.1016/j.jaip.2024.01.006
作者：Alexandra M. Nanzer PhD , Anne-Catherine Maynard-Paquette MD , Vardah Alam MSc , Linda Green MSc , Louise Thomson MSc , Jodie Lam BSc , Mariana Fernandes BSc , Cris
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundEosinophilic granulomatosis with polyangiitis (EGPA) is a multisystemic disease characterized by eosinophilic tissue inflammation. Benralizumab, an anti-IL-5 receptor (anti-IL-5R)

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAqueous eye drop formulations: Cyclodextrins as enabling excipients